News from insmed incorporated A wide array of domestic and global news stories; news topics include politics/government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle.

Latest

Oct 07, 2019, 16:05 ET Insmed Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

Insmed Incorporated (Nasdaq:INSM), a global biopharmaceutical company on a mission to transform the lives of patients with serious and rare diseases, ...


Sep 05, 2019, 16:05 ET Insmed Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

Insmed Incorporated (Nasdaq:INSM), a global biopharmaceutical company on a mission to transform the lives of patients with serious and rare diseases, ...


Sep 03, 2019, 08:00 ET Insmed to Present at Two September Conferences

Insmed Incorporated (Nasdaq: INSM), a global biopharmaceutical company on a mission to transform the lives of patients with serious and rare...


Aug 02, 2019, 16:05 ET Insmed Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

Insmed Incorporated (Nasdaq:INSM), a global biopharmaceutical company on a mission to transform the lives of patients with serious and rare diseases, ...


Aug 01, 2019, 07:30 ET Insmed Reports Second Quarter 2019 Financial Results and Provides Business Update

Insmed Incorporated (Nasdaq:INSM), a global biopharmaceutical company on a mission to transform the lives of patients with serious and rare diseases, ...


Jul 25, 2019, 08:00 ET Insmed to Host Second Quarter 2019 Financial Results Conference Call on Thursday, August 1, 2019

Insmed Incorporated (Nasdaq:INSM), a global biopharmaceutical company on a mission to transform the lives of patients with serious and rare diseases, ...


Jul 02, 2019, 16:05 ET Insmed Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

Insmed Incorporated (Nasdaq:INSM), a global biopharmaceutical company on a mission to transform the lives of patients with serious and rare diseases, ...


Jun 26, 2019, 16:41 ET Insmed Announces Closing of Public Offering of Common Stock

Insmed Incorporated (Nasdaq: INSM) today announced the closing on June 25, 2019 of the issuance of an additional 1,442,307 shares of common stock...


Jun 06, 2019, 08:00 ET Insmed to Present at the Goldman Sachs 40th Annual Global Healthcare Conference

Insmed Incorporated (Nasdaq:INSM), a global biopharmaceutical company on a mission to transform the lives of patients with serious and rare diseases, ...


Jun 04, 2019, 16:05 ET Insmed Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

Insmed Incorporated (Nasdaq: INSM), a global biopharmaceutical company on a mission to transform the lives of patients with serious and rare...


May 24, 2019, 11:27 ET Insmed Announces Closing of Public Offering of Common Stock

Insmed Incorporated (Nasdaq: INSM) today announced the closing of the previously announced public offering of its common stock. Insmed issued and...


May 21, 2019, 20:56 ET Insmed Announces Pricing of Public Offering of Common Stock

Insmed Incorporated (Nasdaq: INSM) announced today that it priced a registered underwritten public offering of 9,615,385 shares of its common stock,...


May 20, 2019, 16:05 ET Insmed Announces Proposed Public Offering of Common Stock

Insmed Incorporated (Nasdaq: INSM) announced today that it has commenced an underwritten public offering of up to $250 million of its common stock....


May 20, 2019, 16:01 ET New Phase 3 Data Show Sustainability and Durability of Culture Conversion with ARIKAYCE® (amikacin liposome inhalation suspension) in Patients with Refractory MAC Lung Disease

Insmed Incorporated (NASDAQ: INSM), a global biopharmaceutical company on a mission to transform the lives of patients with serious and rare...


May 07, 2019, 07:30 ET Insmed Reports First Quarter 2019 Financial Results and Provides Business Update

Insmed Incorporated (Nasdaq: INSM), a global biopharmaceutical company on a mission to transform the lives of patients with serious and rare...


Apr 30, 2019, 08:00 ET Insmed to Host First Quarter 2019 Financial Results Conference Call on Tuesday, May 7, 2019

Insmed Incorporated (Nasdaq:INSM), a global biopharmaceutical company on a mission to transform the lives of patients with serious and rare diseases, ...


Apr 09, 2019, 16:36 ET Insmed Granted Additional U.S. Patent For ARIKAYCE® (amikacin liposome inhalation suspension), Strengthening Brand's Global Patent Portfolio

Insmed Incorporated (Nasdaq:INSM), a global biopharmaceutical company on a mission to transform the lives of patients with serious and rare diseases, ...


Apr 08, 2019, 05:00 ET Insmed Provides Update on ARIKAYCE® (amikacin liposome inhalation suspension) U.S. Launch

Insmed Incorporated (Nasdaq:INSM), a global biopharmaceutical company on a mission to transform the lives of patients with serious and rare diseases, ...


Apr 02, 2019, 16:05 ET Insmed Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

Insmed Incorporated (Nasdaq: INSM), a global biopharmaceutical company on a mission to transform the lives of patients with serious and rare...


Apr 01, 2019, 16:05 ET Insmed To Showcase New ARIKAYCE® (amikacin liposome inhalation suspension) And Pipeline Data At American Thoracic Society International Conference

Insmed Incorporated (Nasdaq:INSM), a global biopharmaceutical company on a mission to transform the lives of patients with serious and rare diseases, ...


Apr 01, 2019, 08:00 ET Insmed to Present at the H.C. Wainwright Global Life Sciences Conference

Insmed Incorporated (Nasdaq: INSM), a global biopharmaceutical company on a mission to transform the lives of patients with serious and rare...


Mar 27, 2019, 16:15 ET Insmed Announces Management Changes

Insmed Incorporated (Nasdaq: INSM), a global biopharmaceutical company on a mission to transform the lives of patients with serious and rare...


Mar 04, 2019, 16:05 ET Insmed Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

Insmed Incorporated (Nasdaq: INSM), a global biopharmaceutical company on a mission to transform the lives of patients with serious and rare...


Feb 22, 2019, 07:30 ET Insmed Reports Fourth Quarter and Full Year 2018 Financial Results and Provides Business Update

Insmed Incorporated (Nasdaq: INSM), a global biopharmaceutical company on a mission to transform the lives of patients with serious and rare...


Feb 20, 2019, 08:00 ET Insmed to Present at the Leerink Partners 8th Annual Global Healthcare Conference

Insmed Incorporated (Nasdaq:INSM), a global biopharmaceutical company on a mission to transform the lives of patients with serious and rare diseases, ...